Previous experimental results derived by the authors’ team showed that the downregulation of ILK inhibited the proliferation and migration of ESCC cells, suggesting that ILK may play an important role in the progression of ESCC. This evidence concerns the gene ILK and esophageal squamous cell carcinoma.